The Devyser blog

On October 26th, we hosted an insightful webinar by Prof. Milan Macek (M.D., DSc.), where he...

Devyser has been awarded a tender for Devyser’s CFTR fragment analysis products, that are used for...

Devyser has been awarded a tender for Devyser RHD, its product for non-invasive fetal RHD status in...

Meet Silvia Borras, a Development Lead and Clinical Scientist in Genetics and Molecular Pathology...

“Devyser is reporting record sales growth (+50% organic growth) for the third quarter, a further...

Bioiatriki is a leading medical laboratory in Greece, providing a range of prenatal genetic testing...

Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from...

The American College of Medical Genetics and Genomics (ACMG) has released an updated position...

A better patient care is the final objective for Dr. Helena Devos and the team at Sint Jan’s...

Devyser has inaugurated its CLIA-certified laboratory in Atlanta, Georgia. The laboratory will...

Devyser is thrilled to announce the launch of two new products, Devyser LynchFAP and Devyser BRCA...

Fetal derived cell-free DNA (cfDNA) is a key analyte for determining fetal RHD status in plasma...